HepaVue Revenue

Biotechnology Research • • 1-10 Employees

HepaVue revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	$113,400

Key Contact at HepaVue

Maxime Nachit

Co-Founder & CEO

Company overview

Headquarters	XX
Website	hepavue.com
NAICS	541714
Keywords	Biotech, Diagnostics, Medical Imaging, Liver Diseases
Founded	2023
Employees	1-10
Socials

HepaVue Email Formats

HepaVue uses 1 email format. The most common is {first initial} (e.g., j@hepavue.com), used 100% of the time.

Format	Example	Percentage
{first initial}	j@hepavue.com	100%

About HepaVue

Over 2 billion people – more than a quarter of the world population – suffer from chronic liver disease. Today, the needle biopsy remains the only diagnostic option. This method is fraught with disadvantages. It is expensive, painful, resource-intensive, samples only a tiny part of the liver and carries a bleeding/mortality risk. As such it is unsuitable for mass screening. This shortcoming - coupled with liver diseases progressing silently - results in 70% of patients going unnoticed until terminal stage (cirrhosis). HepaVue has developed the world’s first virtual liver biopsy which will make liver disease diagnosis affordable, painless, safe and more accessible. Our technology will prevent avoidable cases of liver cancer, transplantations and deaths.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

HepaVue has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore HepaVue's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-12-12	12	$113,400

Funding Insights

$113,400

Total funding amount

$113,400

Most recent funding amount

Number of funding rounds

HepaVue Tech Stack

Discover the technologies and tools that power HepaVue's digital infrastructure, from frameworks to analytics platforms.

Marionette.js

JavaScript frameworks

Underscore.js

JavaScript libraries

jQuery

JavaScript libraries

Nginx

Reverse proxies

PHP

Programming languages

Open Graph

Miscellaneous

Selectize

JavaScript libraries

WordPress

Blogs

anime.js

JavaScript graphics

Backbone.js

JavaScript frameworks

Swiper

JavaScript libraries

MySQL

Databases

Frequently asked questions

HepaVue is located in XX.

HepaVue generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

HepaVue has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

HepaVue was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

HepaVue has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

HepaVue has raised a total of $113,400 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at HepaVue

Maxime Nachit

Co-Founder & CEO

4.8

40,000 users